pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monoclonal Antibody · news · pharmadog
← back to Monoclonal Antibody
News · Monoclonal Antibody
552
stories
9h
Adecto, Aviceda shut down
biospace
9h
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
biopharma dive
10h
FDA extends review of Novo’s hemophilia A drug, citing manufacturing issues
biospace
10h
AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
biospace
13h
The top biopharma conferences in 2027
biopharma dive
14h
AbbVie, Genmab trot out first-line DLBCL win for Epkinly in challenge to Polivy
endpoints
14h
ArriVent’s phase 3 lung cancer trial flops, sinking stock
fiercebiotech
16h
Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms
endpoints
21h
BioSpace 40 Under 40 winners make their mark on biopharma
biospace
1d
2 Massachusetts biotechs call it quits
biospace
1d
Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansion
endpoints
1d
Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset
biospace
1d
CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential
biospace
1d
Biogen’s big lupus bet gets boost from new durability data for skin disease
biospace
1d
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
stat
1d
Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots
fiercebiotech
1d
Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere
fiercebiotech
1d
Opinion: FDA must ensure American patients can access new and experimental drugs
biospace
4d
BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffs
biospace
4d
Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone
endpoints
4d
‘We’ve been taking our time’: Buzzy AI biotech Xaira reveals antibody platform, first taste of pipeline
fiercebiotech
4d
Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down
fiercebiotech
5d
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
5d
Sanofi, Regeneron broaden alliance to find their next Dupixent
biopharma dive
5d
United Therapeutics' legal victory; BMS' Camzyos approved for kids
endpoints
5d
Merck’s antibody impresses with ‘highly competitive’ data in chronic skin disease
biospace
5d
Pfizer’s eczema drug clears skin in mid-stage trial
biopharma dive
5d
#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy
endpoints
5d
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
stat
5d
Sanofi builds on immunology alliance with Regeneron for $1B upfront
endpoints
← prev
page 1 of 19
next →
